Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2026)

Organogenesis Holdings has reported Tax Provisions over the past 9 years, most recently at $10.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 296.4% year-over-year to $10.2 million; the TTM value through Dec 2025 reached $438000.0, up 111.94%, while the annual FY2025 figure was $438000.0, 111.94% up from the prior year.
  • Tax Provisions for Q4 2025 was $10.2 million at Organogenesis Holdings, up from -$407000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $10.2 million in Q4 2025 and troughed at -$32.1 million in Q4 2021.
  • A 5-year average of -$1.3 million and a median of $122500.0 in 2021 define the central range for Tax Provisions.
  • On a YoY basis, Tax Provisions climbed as much as 1703.7% in 2021 and fell as far as 8207.58% in 2021.
  • Year by year, Tax Provisions stood at -$32.1 million in 2021, then surged by 97.78% to -$712000.0 in 2022, then crashed by 72.47% to -$1.2 million in 2023, then surged by 310.1% to $2.6 million in 2024, then soared by 296.4% to $10.2 million in 2025.
  • Business Quant data shows Tax Provisions for ORGO at $10.2 million in Q4 2025, -$407000.0 in Q3 2025, and -$2.4 million in Q2 2025.